PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2013

PHARMANIAGA BERHAD

Financial Year End

31/12/2013
Quarter4
Quarterly report for the financial period ended31/12/2013
The figureshave not been audited

Attachments

KLSE 1213.pdf
371 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2013

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2013
31/12/2012
31/12/2013
31/12/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
567,860
482,404
1,946,639
1,812,346
2Profit/(loss) before tax
33,007
4,248
92,997
103,313
3Profit/(loss) for the period
21,267
-7,468
56,761
63,205
4Profit/(loss) attributable to ordinary equity holders of the parent
20,813
-7,934
55,200
61,710
5Basic earnings/(loss) per share (Subunit)
8.04
-3.06
21.32
23.84
6Proposed/Declared dividend per share (Subunit)
6.20
4.55
16.02
15.92


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.8800
1.8200

Remarks :
The weighted average number of ordinary shares in issue for the purpose of the computation of the earnings per share had been adjusted retrospectively to reflect the Company's share split and bonus issue which were completed on 5 June 2013.
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence

Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced24 Feb 2014  
CategoryFinancial Results
Reference NoPB-140220-36361

View original report